Samir Ranjan Panda

机构：University of California, San Francisco, Siksha O Anusandhan University, National Institute of Pharmaceutical Education and Research, Indian Institute of Technology Bhubaneswar · ORCID：0000-0001-5327-7917

发表论文 37 篇 · 总被引 795 次 · h-index 17

代表论文

• Loganic acid protects against ulcerative colitis by inhibiting TLR4/NF-κB mediated inflammation and activating the SIRT1/Nrf2 anti-oxidant responses in-vitro and in-vivo (2023 · International Immunopharmacology · 被引 50)
• AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma (2023 · JHEP Reports · 被引 29)
• Ambient particulate matter (PM2.5) exposure contributes to neurodegeneration through the microbiome-gut-brain axis: Therapeutic role of melatonin (2023 · Environmental Toxicology and Pharmacology · 被引 29)
• Targeting TLR4/3 using chlorogenic acid ameliorates LPS+POLY I:C-induced acute respiratory distress syndrome via alleviating oxidative stress-mediated NLRP3/NF-κB axis (2023 · Clinical Science · 被引 28)
• Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis (2023 · International Immunopharmacology · 被引 26)
• AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis (2023 · Chemico-Biological Interactions · 被引 24)